Lifecare – Letter from the CEO

Bergen, Norway 5 Januar 2023 

2022 was a very good year for Lifecare as a company and we welcome 2023
expecting continued significant progress in our mission to make life easier for
patients with diabetes. 

Throughout 2022 Lifecare disclosed several milestone events, read more in letter
from Lifecare's CEO published today: https://lifecare.no/news/happy-new-year/


This is Lifecare: 
Lifecare is a Bergen-based technology company developing a miniaturized
implantable long-term sensor for correct and continuous monitoring of blood
sugar in people with diabetes. The Company's patented technology also has the
potential for use in various biomarkers. Lifecare AS is listed on Euronext
Growth (LIFE). 

Further information Joacim Holter, CEO, Lifecare AS, joacim.holter@lifecare.no,
+47 40 05 90 40 

This stock exchange announcement was published by Joacim Holter, CEO at Lifecare
AS, on 5.1.23 at 14:00 CET.